Multinational clinical trials surpass domestic trials in first quarter

The number of multinational clinical trials conducted by transnational pharmaceutical companies in Korea surpassed that of trials by domestic firms in the first quarter of this year, pointing to the rapid development of the local clinical experimentation sector, the Korea Food and Drug Administration said recently.

The nation's drug watchdog said it approved 45 such trials for foreign-invest...